Atlas Trials

A Study of BMN 255 in Participants With Non-Alcoholic Fatty Liver Disease And Hyperoxaluria

Clinical trial NCT06138327 · WITHDRAWN

Trial details

NCT number
NCT06138327
Sponsor
BioMarin Pharmaceutical
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
HyperoxaluriaNonalcoholic Fatty Liver DiseaseKidney Stone
Start date
2023-09-26
Primary completion
2024-03-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.